Bryan Norman

Bryan joined Enveda after spending >25 years in big pharma drug discovery (Searle, Eli Lilly), where he led multiple cross-functional drug discovery efforts, many of which culminated in clinical candidates for oncology, endocrine and pain indications. He has published > 50 papers in peer-reviewed scientific journals, and is an inventor on > 30 U.S. patents. Bryan is also an Adjunct Professor at the Indiana University School of Medicine, where he teaches multiple drug discovery topics. He serves on the Editorial Board of Burger’s Medicinal Chemistry, Drug Discovery and Development and is currently on the Board of Directors of the Medicinal and Bioorganic Chemistry Foundation. Bryan enjoys photography and hitting the links.